OTC Recalls Aside, J&J Says Business Still Burdened By Economic Factors
This article was originally published in The Rose Sheet
Executive Summary
Johnson & Johnson concedes that even without the fallout from a recent string of OTC drug recalls, its consumer healthcare business would have been "flat to slightly down" for the quarter